4//SEC Filing
Papapetropoulos Spyridon 4
Accession 0001328143-21-000060
CIK 0001328143other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 4:16 PM ET
Size
7.4 KB
Accession
0001328143-21-000060
Insider Transaction Report
Form 4
Papapetropoulos Spyros
Director
Transactions
- Award
Common Stock
2021-06-02+5,000→ 20,975 total - Award
Stock Option (Right to Buy)
2021-06-02+10,000→ 10,000 totalExercise: $5.21From: 2022-06-02Exp: 2031-06-01→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest on the one year anniversary of the grant date, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of such date.
- [F2]The Option shares vest in full on the one year anniversary of the grant date, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of such date.
Documents
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeother
Related Parties
1- filerCIK 0001832694
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 4:16 PM ET
- Size
- 7.4 KB